Beth established her contract research consulting company in 1999. Throughout her long career, she has provided operational oversight for early and late phase programs for Fortune 500 companies, including global submissions of blockbuster products. Beth has contributed to advancements in a multitude of therapeutic areas, including oncology, CNS, and clinical pharmacology.
In 2015, Beth expanded and renamed her company to Trialwise, a boutique CRO specializing in early phase studies. As the founder and president of Trialwise, Beth oversees a skilled team conducting clinical research for Phase 1 and 2 studies from planning through execution, and regularly consults with select private and government clients. Her expertise includes the complexities of data sources and their interface with clinical databases, data monitoring, the CRO landscape, and Good Clinical Practice.
Beth studied psychology and zoology at Brigham Young University and holds an MBA from the C.T. Bauer College of Business at the University of Houston.
President and CEO
Principal Clinical Research Consultant
With a career spanning more than 40 years as an architect and IT professional, Larry brings a unique perspective on constructing innovative technological solutions to support all aspects of the company’s operations.
Larry also maintains the role of creative director, managing Trialwise’s branding and external communications. Prior to his current position, he was a lecturer and visiting critic at the Rice University School of Architecture for almost two decades. He also ran the award-winning news website Swamplot.com for 12 years, and has been a contributing writer, editor, and photographer for national and local publications.
Larry holds an undergraduate degree from Yale University and a graduate degree from Rice University.
In her role as the Director of Project Management, Peggy leads cross-functional projects with a level of thoroughness only an experienced professional from both the sponsor and site perspectives can deliver.
Early in her career, Peggy conducted research into the molecular biology of autoimmune disease and HSV infection. Later, her focus shifted to research and development of a novel enzyme replacement therapy for the treatment of Pompe disease, as well as a new molecular entity for the management of severe pain.
Peggy’s segue into clinical research came as development of a new chemical entity progressed to the initiation of clinical trials. She continued to advance in her career at several start-up biotechnology companies to Director of Project Management before joining Trialwise.
Peggy graduated with a BS in Biology from the University of Dallas.
Liz began her career in academia as an oncology study/data coordinator at the University of Nebraska Medical Center where she had the opportunity to coordinate investigator-initiated trials as well as those driven by sponsor companies and cooperative study groups. After 5 years in a site role, Liz transitioned to work for a sponsor company and several contract research organizations with increasing levels of responsibility as both a CRA and study manager. In addition to oncology, Liz has continued to advance her career working across multiple therapeutic areas and phases of research.
Liz received her bachelor’s degree from the College of St. Mary and master’s degree in Public Administration from the University of Nebraska Omaha.
Liz is a member of the Association of Clinical Research Professionals (ACRP) and is a Certified Clinical Research Associate (CCRA).